The growing problem of chronic renal failure after transplantation of a nonrenal organ

New England Journal of Medicine

Volumn 349, Issue 10, 2003, Pages 994-996

  Magee, Colm ^a   Pascual, Manuel ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CALCINEURIN INHIBITOR; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TACROLIMUS;

ACUTE KIDNEY FAILURE; ANEMIA; BONE DISEASE; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; DIABETES MELLITUS; DIALYSIS; EDITORIAL; GLOMERULUS FILTRATION RATE; HEPATITIS C; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MORTALITY; NONRENAL ALLOGRAFT; NONRENAL ORGAN TRANSPLANTATION; ORGAN TRANSPLANTATION; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSORIASIS; SURVIVAL; THROMBOTIC THROMBOCYTOPENIC PURPURA; URINE SEDIMENT;

HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; ORGAN TRANSPLANTATION;

EID: 0041859226     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMe038120     Document Type: Editorial

References (16)

1. Denton MD, Magee CC, Sayegh MH. Immunosuppressive strategies in transplantation. Lancet 1999;353:1083-91.
2. Wilkinson AH, Cohen DJ. Renal failure in the recipients of nonrenal solid organ transplants. J Am Soc Nephrol 1999;10:1136-44.
3. Magee CC, Premkumar P. Jarcho JJ, Denton MD. High prevalence of hematologic markers of thrombotic microangiopathy in cardiac transplant recipients: relationship to renal function .Am J Transpl 20033:Suppl 5:196A. abstract.
4. Myers BD, Newton L. Cyclosporine-induced chronic nephropathy: an obliterative microvascular renal injury. J Am Soc Nephrol 1991; 2:Suppl 1:S45-S52.
5. Young EW, Ellis CN, Messana JM, et al. A prospective study of renal structure and function in psoriasis patients treated with cyclosporin. Kidney Int 1994;46:1216-22.
6. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003;349:931-40.
7. National Kidney Foundation (NKF) Kidney Disease Outcome Quality Initiative (K/DOQI) Advisory Board. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification: Kidney Disease Outcome Quality Initiative, Am J Kidney Dis 2002;39:Suppl 2:S1-S246.
8. Renal Data System. USRDS 2002 annual data report: atlas of end-stage renal disease in the United States. Bethesda, Md.; National institute of Diabetes and Digestive and Kidney Diseases, 2002. (Also available at http://www.usrds.org.)
9. St Peter WL, Schoolwerth AC, McGowan T McClellan WM. Chronic kidney disease: issues and establishing programs and clinics for improved patient outcomes. Am J Kidney Dis 2003;41:903-24.
10. Gridelli B, Remuzzi G. Strategies for making more organs available for transplantation. N Engl J Med 2000;343:404-10.
11. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002;346:580-90.
12. Pascual M, Curtis J, Delmonico F, et al. A prospective randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation. Transplantation 2003; 75:1501-5.
13. Tedoriya T, Keogh AM, Kusano K, et al. Reversal of chronic cyclosporine nephrotoxicity after heart transplantation - potential role of mycophenolate mofetil. J Heart Lung Transplant 2002;21:976-82.
14. Soccal PM, Gasche Y, Favre H, Spiliopoulos A, Nicod LP. Improvement of drug-induced chronic renal failure in lung transplantation. Transplantation 1999;68:164-5.
15. Matthews JB, Ramos E, Bluestone JA. Clinical trials of transplant tolerance: slow but steady progress. Am J Transplant 2003;3:794-803.
16. Chobanian AV, Bakris GL, Black HP, et al. The Seventh Peport of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72. [Erratum, JAMA 2003;290:197].